|
MAS patients (n=20) |
MAS patients (n=20) |
Non-MAS patients (n=68) |
Non-MAS patients (n=68) |
|
|
Admission |
Day 5 of treatment |
Admission |
Day 5 of treatment |
p |
WBC (/µL) |
9133.7 ± 7270.7 |
8915 ± 5886.2 |
6760.1 ± 2324.1 |
6705.5 ±
2191.9 |
0.17 / 0.01
|
Lymphocytes (/µL) |
821.1 ± 405.9 |
1028.8 ± 670.9 |
1794.7 ± 872.5 |
2028.2 ± 847,9 |
0.001 / 0.001 |
Neutrophils (/µL) |
7513.2 ± 6404.7 |
7353.1 ± 5602.8 |
4316.3 ± 1896.9 |
3996.5 ± 1807.1 |
0.04 / 0.001 |
NLR |
13.3 ± 15.1 |
11.6 ± 16.6 |
3.1 ± 2.6 |
2.4 ± 2 |
0.008 /
0.001 |
AST (U/L) |
42.2 ± 19.7 |
63.4 ± 66.2 |
30.3 ± 20.3 |
23.9 ± 9.7 |
0.02 / 0.001
|
ALT (U/L) |
36.4 ± 28.3 |
44.4 ± 34.5 |
29.2 ± 24.5 |
28 ± 18.6 |
0.273
/ 0.01
|
LDH (U/L) |
451.3 ± 304.3 |
557.1 ± 296.1 |
270.5 ± 118.5 |
242 ± 95.1 |
0.001 / 0.001 |
GGT (U/L) |
57 ± 47.1 |
72.3 ± 54.8 |
33.3 ± 23.2 |
32.6 ± 23.7 |
0.04 / 0.001 |
ALP (U/L) |
81.7 ± 33.9 |
66.1 ± 29.3 |
77.1 ± 42.3 |
70 ± 37.2 |
0.66 /
0.61 |
Sodium (mmol/L) |
137.5 ± 6.1 |
145.2 ± 7.8 |
139.1 ± 3.1 |
139.6 ± 2.4 |
0.3 / 0.001
|
Potassium (mmol/L) |
4.2 ± 0.6 |
4.5 ± 0.7 |
4.2 ± 0.4 |
4.4 ± 0.5 |
0.8
/ 0.49 |
Creatine (mg/dL) |
1.8 ± 1.8 |
2.1 ± 1.8 |
0.9 ± 0.5 |
0.8 ± 0.2 |
0.04 / 0.001 |
Prothrombin time (s) |
20.4 ± 12.4 |
19.6 ± 9.3 |
14.7 ± 3.5 |
13.3 ±
1.8 |
0.04 / 0.001 |
CRP (mg/dL) |
176.7 ± 75.7 |
50.9 ± 29.8 |
27.7 ± 38.7 |
11.2 ± 18.4 |
0.001 / 0.001 |
Troponin-I (ng/dL) |
276.1 ± 607.3 |
674 ± 2517.9 |
8.9 ± 15.3 |
3.2 ± 6 |
0.001 / 0.02 |
PaO2/FiO2
|
209.8 ± 67.7 |
296.3 ± 42.4 |
318.9 ± 47.6 |
331.7 ± 46.4 |
0.001 /
0.004
|
D-Dimer
(ng/mL)
|
2529.9 ± 3111.7
|
1327 ± 1425.5
|
766.6 ± 955.2
|
476.7 ± 616.6
|
0.03 / 0.001
|
Ferritin (ng/mL) |
1094.4 ± 1559.9 |
490.3 ± 75.6 |
346.7 ± 144.1 |
134.6 ± 76.4 |
0.001 / 0.001 |
MCP-1 (pg/ml) |
353.1 ± 223.3 |
190.8 ± 170.9 |
49.9 ± 65.5 |
25.1 ±
20.9 |
0,001 / 0,001 |
SP-A (pg/ml) |
534.7 ± 388.7 |
245.4 ± 120.1 |
346.3 ± 345.6 |
180.6 ±
110.8 |
0,05 / 0,04 |